Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee
recovery Helps people fall asleep faster and spend more time in deep, restorative sleep
In the randomized Semaglutide Treatment Effect in People with Obesity (STEP) 1 trial (intent to treat: 1,961 adults with overweight or obesity without T2D), once-weekly subcutaneous semaglutide 2.4 mg resulted in greater weight loss compared with placebo over a 68-week period (estimated treatment difference 12.4 percentage points, 95% confidence interval (CI) 13.4, 11.5
Not so long ago, male patients who had been prescribed Ozempic started to share their stories about the surprising side effect they started experiencing after using Ozempic for some time
Men and women largely agree on the factors influencing weight
Scenario 1: Planned Discontinuation With Good Outcomes The best-case scenario: Made substantial lifestyle changes during treatment Achieved modest, sustainable weight loss Eating patterns feel genuinely different, not forced Exercise is established routine Weight remains stable after stopping (within 5-10% of lowest) Maintained vigilance catches any creep early What this looks like: You stop medication and appetite returns but is manageable You maintain most of your weight loss through established habits Some weight returns but you stabilize at an acceptable level Years later, youre still at a significantly lower weight than baseline Likelihood: This represents the minority of patients